Suppliers / Vasudha Pharma Chem

Vasudha Pharma Chem

India 22 employees Updated 9 July 2026

Vasudha Pharma Chem is an API manufacturer based in India. It holds 66 active US drug master files. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 12 September 2025 as VAI.

66
active US DMFs
0
valid CEPs
4
registered plants 3 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 12 September 2025 VAI US FDA
  • 14 March 2025 VAI US FDA
  • 13 September 2024 VAI US FDA
  • 1 November 2019 NAI US FDA
  • 1 June 2018 VAI US FDA
  • 30 November 2017 VAI US FDA
  • 8 September 2017 NAI US FDA
  • 24 April 2015 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Anakapalli, India 3012160303
Hyderabad, India 3002093078
Visakhapatnam, India Not on file
Ankapalli (D), India 3009822397

What they file, and where

Molecule Regulators Docs
Pantoprazole SFDA (Saudi Arabia), US FDA 6
Loratadine SFDA (Saudi Arabia), US FDA 5
Diatrizoate US FDA 4
Fexofenadine SFDA (Saudi Arabia), US FDA 4
Amitriptyline SFDA (Saudi Arabia), US FDA 3
Esomeprazole SFDA (Saudi Arabia), US FDA 3
Ketorolac SFDA (Saudi Arabia), US FDA 3
Losartan SFDA (Saudi Arabia), US FDA 3
Aripiprazole US FDA 2
Cisapride US FDA 2
Show all 30 molecules on file
Clopidogrel US FDA 2
Cyclobenzaprine US FDA 2
Cyproheptadine US FDA 2
Desloratadine US FDA 2
Diltiazem US FDA 2
Donepezil US FDA 2
Itraconazole US FDA 2
Levetiracetam US FDA 2
Loperamide US FDA 2
Mirabegron US FDA 2
Nortriptyline US FDA 2
Olmesartan US FDA 2
Pimozide US FDA 2
Pregabalin US FDA 2
Quetiapine US FDA 2
Rivaroxaban US FDA 2
Rupatadine US FDA 2
Tamsulosin US FDA 2
Telmisartan US FDA 2
Trazodone US FDA 2

Also appears on these molecule pages

Show 10 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None
EMA None 3
US FDA None 3

Comparing suppliers?

Choose your molecules and target markets. Vasudha Pharma Chem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 12 September 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates